QuintilesIMS is releasing a new pharmaceuticals commercial operations SaaS software called Orchestrated Customer Engagement (OCE) in response to customer demand.
The US Food and Drug Administration (FDA) has launched openFDA, a programme allowing web developers and researchers to access “massive” datasets on adverse effects and to use them to build their own applications.
Wipro Technologies has introduced Rapid Trials to provide clients with a data collection platform that can be deployed quickly and with minimal infrastructure investment.
Ingenuity Systems have launched the Ingenuity Pathways Analysis
(IPA) 3.1, a web-based software application that enables biologists
and bioinformaticians to understand biological mechanisms, pathways
and functions.
Despite the best efforts of specialist software development
companies and millions of dollars in spending on dedicated
programmes, the most commonly used package in the drug discovery
laboratory is Microsoft's office workhorse...